• 37166 Citations
  • 95 h-Index
1982 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 14 Similar Profiles
Stomach Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Stomach Medicine & Life Sciences
Survival Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Esophagogastric Junction Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

A balancing act: dual immune-checkpoint inhibition for oesophagogastric cancer

Harada, K., Abdelhakeem, A. A. F. & Ajani, J. A., Jan 1 2019, In : Nature Reviews Clinical Oncology. 16, 1, p. 9-10 2 p.

Research output: Contribution to journalComment/debate

CD274 Antigen
Adenocarcinoma
Biomarkers
Morbidity
Mortality

A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer

Bang, Y. J., Kang, Y. K., Ng, M., Chung, H. C., Wainberg, Z. A., Gendreau, S., Chan, W. Y., Xu, N., Maslyar, D., Meng, R., Chau, I. & Ajani, J. A., Feb 1 2019, In : European Journal of Cancer. 108, p. 17-24 8 p.

Research output: Contribution to journalArticle

Esophagogastric Junction
Stomach
Disease-Free Survival
Placebos
Neoplasms

Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer

Shah, M. A., Kang, Y. K., Thuss-Patience, P. C., Ohtsu, A., Ajani, J. A., Van Cutsem, E., Hoersch, S., Harle-Yge, M. L. & de Haas, S. L., Jan 1 2019, In : Gastric Cancer.

Research output: Contribution to journalArticle

Esophagogastric Junction
Stomach
Biomarkers
Survival
Neoplasms
1 Citation (Scopus)
Gastrectomy
Stomach Neoplasms
Neoplasm Metastasis
Drug Therapy
Cell Biology

SOURCE: A registry-based prediction model for overall survival in patients with metastatic oesophageal or gastric cancer

van den Boorn, H. G., Abu-Hanna, A., Ter Veer, E., van Kleef, J. J., Lordick, F., Stahl, M., Ajani, J. A., Guimbaud, R., Park, S. H., Dutton, S. J., Bang, Y. J., Boku, N., Mohammad, N. H., Sprangers, M. A. G., Verhoeven, R. H. A., Zwinderman, A. H., van Oijen, M. G. H. & van Laarhoven, H. W. M., Feb 1 2019, In : Cancers. 11, 2, 187.

Research output: Contribution to journalArticle

Open Access
Esophageal Neoplasms
Stomach Neoplasms
Registries
Survival
Calibration